PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 11, 2022Angiogenesis92 citationsOpen Access

Persistent capillary rarefication in long COVID syndrome

IOIrina OsiaeviASArik Bernard SchulzeGEGeorg Evers

Structured PICO

P
Population
Patients with long COVID syndrome 18 months after infection
O
Outcome
Persistent capillary rareficationsurrogate

COVID-19 infection is associated with persistent capillary rarefication up to 18 months post-infection in patients with long COVID syndrome.

Abstract

Our current data strongly suggest that COVID-19 leaves a persistent capillary rarefication even 18 months after infection. Whether, to what extent, and when the observed damage might be reversible remains unclear.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Osiaevi et al. (2022) studied this question.

synapsesocial.com/papers/69dd5ff8629747396240ca77https://doi.org/10.1007/s10456-022-09850-9
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A clinical case definition of post-COVID-19 condition by a Delphi consensus2021 · 2,657 citations
  2. 2Shape and Biomechanical Characteristics of Human Red Blood Cells in Health and Disease2010 · 606 citations
  3. 3Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China2020 · 18,068 citations
  4. 4Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-192020 · 168 citations
  5. 5Endothelial glycocalyx breakdown is mediated by angiopoietin-22017 · 143 citations